Literature DB >> 33475881

Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases.

Daniel Brock Hewitt1, Timothy M Pawlik1, Jordan M Cloyd2.   

Abstract

Entities:  

Year:  2021        PMID： 33475881     DOI： 10.1245/s10434-020-09586-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  1 in total

1.  ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.

Authors:  Ryota Nakanishi; Eiji Oki; Hirofumi Hasuda; Eiki Sano; Yu Miyashita; Akihiro Sakai; Naomichi Koga; Naotaka Kuriyama; Kentaro Nonaka; Yoshiaki Fujimoto; Tomoko Jogo; Kentaro Hokonohara; Qingjiang Hu; Yuichi Hisamatsu; Koji Ando; Yasue Kimura; Tomoharu Yoshizumi; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2021-03-16       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.